PTGS2 and hepatocellular carcinoma: These results suggest that metronomic Celecoxib treatment inhibited the invasive behavior of HCC cells through the suppression of NFκB transcriptional activity, and the mechanisms involved were independent of the COX-2/PGE2 pathway.